Intravitreal triamcinolone favorable in treating persistent DME
Fort Lauderdale, FL-In the short term, intravitreal triamcinolone acetonide (4 mg) reduces the risk of progressive loss of vision and commonly improves vision in patients with diabetic cystoid foveal edema that persists after laser treatment, said Mark C. Gillies, MD, PhD, at the annual meeting of the Association for Research in Vision and Ophthalmology.
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.